أعضاء هيئة التدريس - جامعة بنها
Arginine dimethylation products in pediatric patients with chronic kidney disease
• 2016
معلومات البحث
المؤلفون
Akram E. El-Sadek a, *, Eman G. Behery b, Ahmed A. Azab a, Naglaa M. Kamal c,
Mostafa A. Salama a, Waleed E. Abdulghany a, Enas A.A. Abdallah c
الكلمات المفتاحية
Not Available
المجلة العلمية
Not Available
الناشر
Not Available
المجلد
Not Available
العدد
Not Available
الصفحات
Not Available
publication.type
International
رابط البحث
Not Available
المواد المرفقة
Not Available
الملخص
Background: arginine and its metabolites have been linked to pediatric chronic kidney disease (CKD).We
aimed to estimate serum levels of argninine (Arg), asymmetric dimethylarginine (ADMA) and symmetric
dimethylarginine (SDMA) in pediatric CKD patients and its relation to altered kidney function.
Patients and methods: 132 pediatric patients with CKD and 120 healthy age and sex matched controls
were compared regarding; serum Arg, ADMA and SDMA levels.
Results: In comparison to their values in control subjects, serum Arg levels were significantly lower;
serum ADMA levels were non-significantly higher, but serum SDMA levels were significantly higher in
CKD patients (p values: < 0.000; ¼ 0.054;
aimed to estimate serum levels of argninine (Arg), asymmetric dimethylarginine (ADMA) and symmetric
dimethylarginine (SDMA) in pediatric CKD patients and its relation to altered kidney function.
Patients and methods: 132 pediatric patients with CKD and 120 healthy age and sex matched controls
were compared regarding; serum Arg, ADMA and SDMA levels.
Results: In comparison to their values in control subjects, serum Arg levels were significantly lower;
serum ADMA levels were non-significantly higher, but serum SDMA levels were significantly higher in
CKD patients (p values: < 0.000; ¼ 0.054;